Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-26-155275
Filing Date
2026-04-15
Accepted
2026-04-14 18:34:17
Documents
3
Period of Report
2026-04-14

Document Format Files

Seq Description Document Type Size
1 6-K d284109d6k.htm 6-K 7953
2 EX-99.1 d284109dex991.htm EX-99.1 12228
3 GRAPHIC g284109dap1.jpg GRAPHIC 16016
  Complete submission text file 0001193125-26-155275.txt   43412
Mailing Address 201-2067 CADBORO BAY RD. VICTORIA A1 V8R 5G4
Business Address 201-2067 CADBORO BAY RD. VICTORIA A1 V8R 5G4 250-590-3968
EUPRAXIA PHARMACEUTICALS INC. (Filer) CIK: 0001581178 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41923 | Film No.: 26862056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)